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INTRODUCTION 
 As access to the Internet grows, more people are seeking information about 
medications online.  Research conducted for the Pew Internet & American Life Project 
reveals that a full third of Americans now go online for information about drugs – a climb 
from 19% in 2002 (Fox, Jones 2009).  This trend bears the potential for health 
improvements as well as dangerous outcomes and has fueled a substantial body of 
research.  To date, much work has been conducted on the quality of drug information 
supplied via the Internet, but surprisingly little is known on the nature of the information 
demanded by the public. 
 Eysenbach (2002) has examined Internet-related phenomena from an 
epidemiological perspective.  In one study (Eysenbach, 2006), he introduced a technique 
for measuring information demand that proved capable of predicting important health 
outcomes, e.g., influenza epidemics.  His ingenious technique involved the purchase of 
flu-related keywords from Google AdSense (Mountain View, CA), which granted him 
aggregated information on the prevalence and geographic location of queries involving 
these terms.  In 2008, Google introduced Insights for Search, an analytics tool that makes 
keyword data publically available.   
 This study will rely on Insights for Search data to gain an understanding of drug 
information demand.  Due to the dearth of information on this subject, this study will be 
exploratory in nature and will seek to provide descriptive statistics on the type of 
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information that people in the United States search for with respect to the most highly 
prescribed drugs.
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LITERATURE REVIEW 
Quality of Online Health Information 
Initially, much of the attention given to online health information was focused on 
the quality of the information available on health and drug Web sites.  Health care 
professionals were concerned by the fact that it had become easier than ever to 
disseminate erroneous and dangerous information.  Many sought to equip the public with 
criteria for evaluating Web sites. 
The title of an early article by Silberg, Lundberg, and Musacchio (1997) warns, 
―Let the Reader and Viewer Beware‖ and introduces metadata-based criteria for the 
evaluation of medical information on the Internet.  A study published in the Journal of the 
American Medical Association motivates a meta-analysis of quality evaluation tools as 
follows:  
The rapid growth of the Internet has triggered an information revolution of 
unprecedented magnitude.  Despite its obvious benefits, the increase in the 
availability of information could also result in many potentially harmful effects on 
both consumers and health professionals who do not use it appropriately. (Jadad 
& Gagliardi, 1998, p. 611)  
 
Kim, Eng, Deering, and Maxfield (1999) published a similar review of quality evaluation 
criteria.  Shon and Musen (1999) also relied on metadata as criteria for evaluating the 
quality of information of medical information in general.  Concerning prescription drug 
information specifically, Hatfield, May, and Markoff (1999) used metadata and other 
criteria to evaluate the information on four Web sites.  
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Quality evaluation research quickly proliferated, and a systematic review of the 
literature was soon conducted.  Eysenbach, Powell, Kuss, and Sa (2002) reviewed 79 
empirical studies.  Quality evaluation research was used to make trustworthy Web sites 
more easily identifiable.  The HONcode (Health on the Net Foundation, Geneva, 
Switzerland) certification system is a prominent example of efforts to guide consumer 
health information seeking behavior towards high quality information Web sites. 
 
Usefulness of Prescription Drug Information 
The quality of prescription drug information can be considered from two 
perspectives – that of the experts evaluating the supply of information, and that of the 
consumers who are demanding it.  Eysenbach points out the importance of identifying 
health information areas ―where there is a knowledge translation gap between best 
evidence (what some experts know) and practice (what most people do or believe), as 
well as markers for ‗high-quality‘ information‖ (Eysenbach, 2002, p. 763).  Indeed, many 
quality evaluation criteria comprehended the need for considering the consumer‘s 
perspective.  For instance, criteria often took into account the usability of a Web site by 
measuring things like average loading time.  Some quality evaluation research 
incorporated criteria relating to the usefulness of health information.   
Criteria concerning the usefulness of drug information sometimes drew on 
federal guidelines concerning the written information provided to consumers at 
pharmacies (Thompson & Graydon, 2009).  Typically, Consumer Medication 
Information (CMI) in the format of leaflets is provided to consumers upon receipt of their 
prescriptions.  Guidelines for the usefulness of CMI were made available in an Action 
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Plan which identified ―steps for assessing, evaluating, and revising these criteria, 
component, and format suggestions as additional information is gathered through 
consumer testing and other appropriate means‖ (Department of Health and Human 
Services, December 1996, p. 20).  Wolf, Davis, Shrank, Neuberger, and Parker (2006) 
examined 40 FDA approved medication guides in order to assess their readability.  Kim 
(2005) measured Perceived Usefulness of CMI in patients at three rheumatology/pain 
clinics in order to develop models capable of predicting CMI use.  Winterstein, Linden, 
Lee, Fernandez, and Kimberlin (2010) evaluated CMI leaflets distributed by pharmacies 
based on federal criteria of usefulness. 
Similar studies have been conducted outside of the United States.  Newby, Drew, 
and Henry (2001) used a telephone survey and follow-up interviews of a random sample 
of Australians from the Hunter region to investigate drug information seeking as well as 
satisfaction and understanding of received information.  In another study, a tool ―for 
measuring consumers‘ perceptions of the comprehensibility, utility, and design quality of 
written medicine information, was tested in Australian consumers‖ (Koo, Krass, and 
Aslani, 2007, p. 951). 
Astrom et al. (2000) used both quantitative and qualitative methods to develop a 
tool for measuring patients‘ drug information preferences.  They relied on data on 
demographic characteristics, an intrinsic desire for information scores, and open-ended 
questions.  Open-ended questions included: ―What kind of information about your 
medicines do you want?‖ (p. 161).  However, only a few example responses are provided 
in the Results section.  The authors‘ introductory remarks provide motivation for the 
present paper: 
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To be satisfied one should have been given the right amount of information and 
also find the information useful.  Satisfaction with information is a subjective 
measurement and does not say anything about quality of information. The key 
questions explored in this study are ‗what?‘ drug information the patient desires, 
‗how?‘ it should be presented and ‗by whom?‘ it should be given. (p. 159) 
 
 These studies all testify to the importance of the consumer‘s circumstances with 
respect to prescription drug information.  Many also highlight the usefulness of the 
information as an important criterion.  However, none of these studies provide usefulness 
criteria that are based on the types of prescription drug information that consumers 
actually seek.  The fact that the term ―information prescription‖ (Leisey & Shipman, 
2007) has currency in this literature is a reflection of a general tendency to impose 
information needs on consumers based on what experts believe they should be exposed 
to.  This is certainly an important approach – perhaps even the more important approach 
– yet it is not so important that the alternative approach taken in this paper should not be 
adopted.  Indeed, these approaches can be complementary. 
 
Prescription Drug Information Seeking Behavior 
Many studies investigate prescription drug information seeking behavior.  In 
addition to the PEW survey mentioned in the Introduction section, there are two large-
sample, quantitative studies.  Baker, Wagner, Singer, and Bundorf (2003) sought ―to 
measure the extent of Internet use for health care among a representative sample of the 
US population‖ (p. 2400).  This study found that a weighted 33% of respondents (un-
weighted n=3,670) had used the Internet or e-mail to learn more about a drug.  Another 
large-sample (n=1,084) study found that ―the Internet tops doctors as the go-to resource 
for information about health- and wellness-related topics.  Whereas 55 percent of online 
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adults ask their physician for health- and wellness-related information, 59 percent resort 
to Internet-based resources‖ (iCrossing, 2008, p. 4).  This study posed the question: ―If 
you had to determine what sources contribute to your decision whether or not to take a 
prescription medication, how important would a suggestion from each of the following 
sources be to you?‖(iCrossing, 2008, p. 7). 11% of respondents identified Internet 
resources as ―Extremely important‖ and 39% chose ―Very important.‖  
A survey using a quota sample drawn from an outpatient pharmacy of the 
National University Hospital in Singapore was used to evaluate patient needs and sources 
of drug information (Ho, Ko, and Tan, 2009).  Among participants who had ever used the 
Internet (n=201), 53% reported having used the Internet as a drug information source.  
This study also found that ―the type of DI that respondents usually wanted involved 
adverse effects (72.6%), dosing (54.7%), indication (54.2%), herb– drug or drug– drug 
interactions (38.8%), and mechanism of action (25.9%).  Relatively few respondents 
were interested in DI about the use of devices such as inhalers (13.4%) and whether the 
drug could be used during pregnancy or breastfeeding (10.9%)‖ (p. 734).  The current 
paper will also investigate the type of drug information sought by patients, but will not 
use a survey method and will focus on the U.S. population, rather than a population of 
mostly Chinese nationals in Singapore (p. 733). 
Some research has focused on developing models that predict health information 
seeking behavior.  Weaver et al. (2009) developed logistic regression models that show 
―home computer ownership, online time per week, and health care system use are all 
positively linked with [internet medical information]-seeking behavior‖ (p. 714).  Koo, 
Krass, and Aslani (2006) used a cross-sectional questionnaire study to investigate the 
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influence of patient factors, e.g., health literacy and coping strategy, on seeking and 
reading written medicine information. 
Qualitative designs have also been used to investigate drug information seeking 
behavior.  Peterson, Aslani, Stud, and Williams (2003) used focus groups to assess how 
consumers searched for and appraised medicines on the Internet.  They found that 
participants ―searched for information on medicines using a range of search techniques 
from simple 1-word searches and advanced techniques to suboptimal techniques 
(Discussion section, para. 4).  They also found that ―many participants searched for 
information on a medicine by typing the brand name into a search engine‖ (Discussion 
section, para. 6).  This finding informs the present paper, which will examine query data 
related to brand names rather than active ingredients, i.e., generic names. 
Another qualitative study used human-computer interactions approaches – 
namely, naturalistic observation in a usability laboratory and interviews – to assess the 
health information retrieval and appraisal techniques of consumers (Eysenbach & Kohler, 
2002).  This work relied on a database of anonymized queries to an ―ask doctor‖ Web 
site.  Zeng et al. (2004) also conducted an interview and observation study and ―found 
that many consumers were unable to find satisfactory information when performing a 
specific query‖ (p. 45).  For this study, the consumers were asked to state a health 
information need as a goal prior to searching. 
An article by Williams, Dennis, and Nicholas (2005) investigated what users were 
looking for on Drugscope via an open question regarding users‘ last site visit.   This work 
also examined information needs with page visit frequency data and found information 
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needs that related to euphoria-seeking behavior and its dangers as well as legislation and 
policy questions.  
The literature on prescription drug information seeking behavior would benefit 
from a study that addresses the types of drug information that are searched for in the 
United States. 
 
Infodemiology 
In a seminal article, Eysenbach (2002) introduces the term ―infodemiology‖ as 
follows:  
A new research discipline and methodology has emerged—the study of the 
determinants and distribution of health information and misinformation—which 
may be useful in guiding health professionals and patients to quality health 
information on the Internet.  Information epidemiology, or infodemiology, 
identifies areas where there is a knowledge translation gap between best evidence 
(what some experts know) and practice (what most people do or believe), as well 
as markers for ―high-quality‖ information. (p. 763). 
 
One application of infodemiology is to complement surveys.  Eysenbach and Kohler 
(2003) ―think that direct analysis of searches elicit a much more accurate picture of what 
people are doing and looking for on the web than for example survey data such as the 
Pew Internet Survey, which currently dominate the literature‖ (p. 229).  In order to 
address the ―surprising dearth of evidence on what consumers are searching for on the 
web and how consumers do it‖ (p. 225) in regard to health information, Eysenbach and 
Kohler conduct a study ―aimed to determine the actual prevalence of health-related 
searches on the web by analyzing search terms entered by people into popular search 
engines and to make some preliminary attempts in qualitatively describing and 
classifying these searches‖ (p. 225).  Likewise, the present paper will attempt to address 
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the ―surprising dearth of evidence on what consumers are searching for on the web,‖ but 
in the health information sub-domain of prescription drug information.  
There is evidence that the concept of infodemiology has taken hold.  In the 
Journal Epidemiology, Lee relates that ―the basic premise of infodemiology is that certain 
information patterns on the Internet may be caused by, or may cause, population-health 
patterns‖ (Lee, 2010, p. 761).  Studies that rely on this premise are beginning to 
proliferate – especially since the launches of Google Trends and Google Insights for 
Search. 
 Work (Ginsberg et al., 2009) published by researchers affiliated with Google and 
the Centers for Disease Control and Prevention (CDC) built on the Influenza surveillance 
study mentioned in the Introduction section.  This culminated in a means ―to estimate 
consistently the current [Influenza-Like Illness] percentage 1-2 weeks ahead of the 
publication of reports by the CDC‘s US Influenza Sentinel Provider Surveillance 
Network‖ (p. 1013).  Other researchers ―found Google Trends to approximate certain 
trends previously identified in the epidemiology of Lyme disease‖ (Seifter, 
Schwarzwalder, Geis, and Aucott, 2010, p. 135). 
Breyer and Eisenberg (2010) assert that ―online search volume can provide useful 
information for epidemiologic study and medical research‖ (p. 585).  This study used 
Insights for Search and tested the hypothesis ―that chronic noninfectious diseases with 
known variations in seasonal incidence (such as diabetes mellitus, blood pressure, 
myocardial infarction, and nephrolithiasis) would show seasonal variations in number of 
searches‖ (p. 584). 
 To date, only one study has used Google query data to investigate prescription 
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drug questions.  Schuster, Rogers, and McMahon (2010) examined certain Google search 
queries related to statins using Trends and Insights for Search.  They conclude that 
―Internet search engine queries for drug information exhibit temporal and geographic 
patterns of healthcare utilization...search engine query data may prove helpful in 
providing payers and policy makers with a new window into healthcare utilization in our 
communities‖ (p. 218).
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METHODOLOGY 
 This section will describe the methodology that this paper uses to address the 
question of the type of information that people in the United States search for with 
respect to the most highly prescribed drugs.  It will begin by laying out the Insights for 
Search data and operational definitions, will proceed to explain choices made in selecting 
queries corresponding to the most highly prescribed drugs, and will end by describing the 
drug information taxonomy and coder arrangement. 
 
Google Insights for Search and Operational Definitions 
 Alexa (Alexa Internet, Inc., San Francisco, CA) ranks Google as the number one 
Web site according to traffic volume both overall and in the United States.  The Online 
Health Search 2006 survey conducted for the PEW Internet and American Life Project 
reports that ―66% of health seekers say their last query began at a general search engine 
like Google or Yahoo‖ (Fox, 2006, p. 5).  This makes Google‘s Insights for Search 
analytic tool a relevant source of data for consumer information seeking behavior related 
to health and drug information.  
 For a given query, Insights for Search offers data sets corresponding to four main 
categories: interest over time, regional interest, top searches, and rising searches.  In this 
paper, ―given query‖ is defined as the query entered into – given to – Insights for Search 
and for which Insights for Search provides data.  Consider the below screenshots 
 15 
corresponding to the given query ―vicodin,‖ the most dispensed drug of 2009. 
 
 
Image 1: Entering the given query “vicodin” into Insights for Search.  Regional, time 
period, and category filters are located on the right side of the interface. 
http://www.google.com/insights/search/#cat=45&q=vicodin&geo=US&cmpt=q 
 
Insights for Search results are specific to time ranges and geographic regions that 
researchers can adjust.  This paper will restrict the geographic region to the United States.  
Data is available from January 2004 to the present.  In most cases the entire 2004-present 
time period will be selected.  However, in some cases the time period will be restricted in 
an attempt to control for a confounding factor – the original FDA approval of a drug.  
Pilot analysis suggested that including query data from time periods between 2004 and 
one year following the FDA approval date for a drug affected results.  Since not all drugs 
to be evaluated had an approval date within the 2004-present time period, date ranges for 
drugs that did have an approval date between 2004 and the present were restricted to one 
year following the drug‘s FDA approval date to the present.  Researchers can also limit 
query data by category.  This paper will restrict all query data by the Health category in 
order to remove data not associated with health information seeking behavior.  Pilot 
analysis suggested that this will remove some results that are associated with other 
categories, especially the Industries category.  
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Image 2: Insights for Search top searches results for the given query “vicodin.” “Side 
effects vicodin” is the fourth top search query; it has a normalized, scaled relative 
frequency of 75. 
http://www.google.com/insights/search/#cat=45&q=vicodin&geo=US&cmpt=q 
 
This paper will examine ―top search queries.‖  In this paper, top search queries 
refer to the top searches query results generated by Insights for Search.  This paper will 
measure the ―normalized, scaled relative frequency‖ of top search queries.  These 
normalized, scaled relative frequencies are also provided by Insights for Search as in 
Image 2 above.  It is important to emphasize that top search queries always correspond to 
a given query.  For instance, ―percocet‖ could not be considered as a top search query 
independently of the given query ―vicodin,‖ since it may be a top search query for given 
queries other than ―vicodin.‖  In these cases it may have a normalized, scaled relative 
frequency value other than 65. 
All Insights for Search data are relative rather than absolute.  They are derived by 
computing ―how many searches have been done for the terms you've entered, relative to 
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the total number of searches done on Google over time‖ (Google, 2010).  That is, each 
data point represents the relative frequency of the given query.  Data are also normalized 
and scaled from 0 to 100.  Insights for Search determines top search results ―by 
examining searches that have been conducted by a large group of users preceding the 
search term you‘ve entered, as well as after‖ (Google, 2010).   
This paper will perform further computations to this data to enable certain 
comparisons.  Consider again the given query ―vicodin‖ which yields 49 top search 
queries.  ―Side effects vicodin‖ is among these top search queries; it has a normalized, 
scaled relative frequency of 75.  ―Vicodin dosage‖ is also among the top search queries; it 
has a normalized, scaled relative frequency of 35.  Without further computation it is 
possible to compare the ―importance‖ of ―side effects vicodin‖ to ―vicodin dosage‖: ―side 
effects vicodin‖ is about twice as ―important‖ as ―vicodin dosage.‖  But comparisons 
using the normalized, scaled relative frequencies are only valid within top search results 
for a given query.  In other words, without further computation, it is not possible to 
compare ―side effects vicodin‖ as a top search for the given query ―vicodin‖ to ―lipitor 
side effects‖ as a top search query for ―lipitor.‖ 
Fortunately, the calculation that allows this comparison is straightforward.  First, 
the normalized, scaled relative frequency for each top search query for a given query is 
divided by the sum of the normalized, scaled relative frequencies of all top search results 
for a given query.  This quotient is then multiplied by 100.  The result of this procedure is 
referred to in this paper as a ―query weight.‖  Return to the example of the top search 
query ―side effects vicodin‖ for the given query ―vicodin.‖  ―Side effects vicodin‖ has a 
normalized, scaled relative frequency of 75.  Dividing this by the sum of the normalized, 
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scaled relative frequencies of all of the top search queries for the given query ―vicodin,‖ 
1380, and multiplying the result by 100 yields a query weight of 5.00.  Using query 
weights will enable comparisons between the top search results of different given queries.  
For instance, the query weight for ― vicodin side effects‖ might be compared to the query 
weight for ―lipitor side effects‖ with respect to the given query ―lipitor‖ which is 20.20.  
This means that ―lipitor side effects‖ is a ―more important‖ top search query with respect 
to the given query ―lipitor‖ than is ―side effects vicodin‖ with respect to the given query 
―vicodin.‖ 
Although this paper seeks to make comparisons across given queries, it will not 
do so by simply comparing the query weights for top search queries.  Doing so poses two 
main problems. The first reason involves the large number of total top search queries.  
One advantage of Insights for Search over Trends is that data sets are available in comma 
separated value data files.  These files are not limited to ten top search queries as shown 
in Image 2.  For instance, the data file for the given query ―vicodin‖ includes 49 top 
search queries.  This study will use all available top search queries, which will yield more 
comprehensive results.  This may also yield more interesting results; the 45
th
 top search 
query corresponding to the given query ―vicodin‖ is ―snort vicodin.‖  However, without 
an a priori rationale for limiting possible comparisons that result from using all top search 
queries, there would be too many potential comparisons. 
More importantly, the question arises as to how to treat top search queries that 
involve similar terms.  For instance, the top search query ―vicodin side effects‖ is very 
similar to ―side effects vicodin.‖  This provides motivation for adding query weights.  If 
such query weights are not added, comparison to similar query weights for different 
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given queries might not be valid.  E.g., if the given query ―lipitor‖ only generated ―side 
effects lipitor‖ and not ―lipitor side effects.‖  On a broader level, this points to a need for 
the top search queries to by categorized, a process that will be described below. 
After all of the top search queries have been fit to the below-described taxonomy, 
the query weights for each drug information type can be computed for each given query.  
Return to the example of the given query ―vicodin,‖ which had three top search queries 
that were coded as falling under the Adverse Effects drug information type.  These query 
weights, 7.60, 6.08, and 2.28 add to 15.96.  This result, 15.96, will be referred to as ―the 
type weight‖ of Adverse Effects for the given query, ―vicodin.‖  Since all query weights 
for a given query sum to 100, these type weights are equivalent to the percentage of 
query weight for each drug information type.  These type weights can be summed over all 
given queries; the Adverse Effects type weight for the given query ―vicodin‖ can be added 
to that for ―lipitor‖ and so forth.  Sum type weights for each drug information type will 
then be divided by the total of the sum type weights for all drug information types and 
then multiplied by 100.  This gives the mean type weights, which are equivalent to the 
percentage of the sum type weights for each drug information type. 
 
Given Query Selection 
 Crucial methodological decisions had to be made regarding given query selection.  
Since this paper aims to explore prescription drug information seeking behavior, selecting 
from the universe of prescription drugs was deemed an appropriate starting point.  There 
is a vast number of FDA approved prescription drugs, however.  Hatfield et al. (1999) 
took the following approach: ―the 30 prescription drugs dispensed in the highest volume 
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to ambulatory care patients were selected to represent those medications for which 
consumers would be seeking information. The drugs to be evaluated (appendix) were 
selected by using the ‗Top 200 Rx Drugs‘ list for 1996‖ (p. 2308).  This paper will follow 
this approach, but it will evaluate the top 50 drugs and will substitute the most current 
version of the Top 200 Rx Drugs list (Bartholow, 2010).  This list is titled, ―Top 200 
Products in the US Market By Dispensed Prescriptions, 2009‖ and the copyright is owned 
by IMS Health. 
 Certain features of this list require decisions regarding given query selection.  
Consider the drug metformin hcl.  Top search queries for the given queries "metformin 
hcl‖ and ―metformin‖ differ widely.  Considering counts alone: only 11 top search 
queries are generated for the former, while 50 are generated for the later.  This paper 
always selects given queries without qualifiers. In this case, the given query ―metformin‖ 
is selected.  Consider Image 3 below, which demonstrates the merit of this approach to 
given query selection.  
 Image 3: Interest over time data for the given queries “metformin” and “metformin 
hcl.”  “Metformin”(top series) maintains a higher normalized, scaled relative frequency 
than “metformin hcl” (bottom series). 
http://www.google.com/insights/search/#cat=45&q=metformin%20hcl%2Cmetformin%2
C&geo=US&cmpt=q 
 
 Another given query selection decision involves the fact that the drug list 
considers a generic drug made by a different manufacturer to be a distinct product.  For 
example, simvastatin manufactured by Teva is ranked 14
th
 and simvastatin manufactured 
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by Dr. Reddy‘s is ranked 26th.  This paper does not consider a generic drug made by 
different manufacturers to be distinct drugs. 
This raises the question of given queries for drugs for which there are no generic 
alternatives.  These ―branded‖ drugs might be referred to by their brand name or by the 
name of their active ingredient (which becomes the generic name after patent expiry).  
Peterson, Aslani, Stud, and Williams (2003) found that ―many participants searched for 
information on a medicine by typing the brand name into a search engine‖ (Discussion 
section, para. 6).  In accord with this, given queries for drugs for which patent expiry has 
not occurred will be the brand name of the drug.  However, in the case of drugs for which 
patent expiry has occurred, this will not always be the case.  For instance, for lisinopril 
the generic name will be selected because it had higher levels of normalized, scaled 
relative frequency than the brand name, Prinivil (see Image 4 below). 
 
Image 4: Interest over time data for the given queries “lisinopril” and “prinivil.”  The 
given query corresponding to the generic name, “lisinopril”(top series) maintains a 
higher normalized, scaled relative frequency than that corresponding to the brand name, 
“prinivil” (bottom series). 
http://www.google.com/insights/search/#cat=45&q=lisinopril%2Cprinivil&geo=US&cm
pt=q 
 
In still other cases, the both the generic and the brand name were used in the given query.  
Consider the drug simvastatin (brand name, Zocor).  Patent expiry for this drug occurred 
in June 2006.  One year after this period, ―zocor‖ had higher normalized, scaled relative 
frequencies than ―simvastatin.‖  However, Image 5 shows that the reverse is true after 
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2008.  Throughout the time period, both given queries had substantial search volumes.  
This problem was circumvented by using the Boolean OR operator, which is ―+‖ in 
Insights for Search). 
 
Image 5: Interest over time data for the given queries “simvastatin+zocor,” 
“simvastatin,” and “zocor.” “Simvastatin+zocor”(top series) captures search volume 
for “simvastatin” OR “zocor.” The given query corresponding to the generic name, 
“simvastatin”(from left, middle series) begins with a higher normalized, scaled relative 
frequency than that corresponding to the brand name, “zocor” (from left, bottom series), 
but this relationship does not hold over the entire time period. 
http://www.google.com/insights/search/#cat=45&q=simvastatin%2Bzocor%2Csimvastat
in%2Czocor&geo=US&date=6%2F2007%2043m&cmpt=q 
 
 In addition to the above reasoning, the final list of given queries was reviewed by 
a medical doctor for face validity.  This final list is provided in the Appendix. 
 
Prescription Drug Query Taxonomy and Coding Top Search Queries 
 For reasons outlined above, this paper will rely on a prescription drug query 
taxonomy.  There is precedent for this in the health information seeking literature.   
Eysenbach and Kohler (2003) used coders to map health related search queries to a pre-
existing taxonomy.  However, ―the Ely taxonomy – originally developed to classify 
physicians‘ information needs – proved not to be very useful to code consumer 
questions‖ (p. 227).  A study by Ho, Ko, and Tan (2009) described the following drug 
information types in relation to consumer Internet drug searching: adverse effects, 
dosing, indication, herb-drug or drug-drug interactions, mechanism of action, use of 
devices such as inhalers, and use during pregnancy.  Pilot analysis shows that this 
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taxonomy would cover many of the top search queries, but that it needs to be modified to 
account for the differences between self-reported drug information needs and prescription 
drug search queries.  The following taxonomy will be used in this study. 
Query Type Example Top Search Queries Forms 
Adverse Effects “[drug name] side effects,” “[drug name] 
rash” 
Dosing “[drug name] 40 mg,” “[drug name] 
daily” 
Indication “[drug name] [indication]” 
Drug-Drug or Herb-Drug Interactions “[drug name] interactions” 
Mechanism of Action “how [drug name] works” 
Fertility, Pregnancy, or Lactation “[drug name] pregnancy,”  
Administration “[drug name] cream,” “[drug name] tabs” 
Drug Substitute or Comparison “[name of another drug in same class],” 
“[name of another drug with the 
indication of the given query drug] 
General or Synonym “[drug name] medication,” “[active 
ingredient name when generic not 
available]”  
Cost or Procurement “buy [drug name],” “[drug name] no 
prescription” 
Other “[drug name] recall” 
Table 1: Drug query taxonomy. 
 Coding will be conducted by a primary coder, PC, who worked independently.  
PC is a licensed, practicing physician.  Furthermore, as a primary care practitioner, PC is 
exposed to a wide variety of prescription drugs.  Pilot analysis suggested that a skilled-
coder arrangement might be necessary for reliability and efficiency.  For instance, a coder 
lacking general awareness of prescription drugs would not know that the top search query 
―ppi‖ refers to the drug class ―proton pump inhibitors.‖  On the other hand, a medical 
doctor can be expected to recognize a wide variety of generic names, drugs within the 
same drug class as the given query drug, and drugs indicated for the same condition as 
the given query drug.  PC was asked to consult the AHFS Drug Information database 
(American Society of Health-System Pharmacists, 2010) to resolve any questions.  PC 
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did not require the use of this reference for coding. 
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RESULTS 
 Below, Table 2 shows the results for each given query type.  The second column 
shows the sum of the weights for each given query type across all given queries.  The 
third column shows the mean type weight across all given queries.  Note that the mean 
type weight for each given query type is equivalent to the percentage of the sum type 
weight. 
Given Query Type Sum Type Weight Mean Type Weight 
Administration 27.21 0.54 
Adverse Effects 834.45 16.69 
Cost or Procurement 122.48 2.45 
Dosing 438.56 8.77 
Drug Substitute or 
Comparison 
1156.50 23.13 
Drug-Drug or Drug-Herb 
Interaction 
132.59 2.65 
Fertility, Pregnancy, or 
Lactation 
28.89 0.58 
General or Synonym 1599.64 31.99 
Indication 336.18 6.72 
Mechanism of Action 9.43 0.19 
Other 314.07 6.28 
Totals 5000 100 
Table 2: Total Weight and Percent Total Weight by Given Query Type. 
 
 General or Synonym was the given query type with the highest mean type weight, 
followed by Drug Substitute or Comparison.  These two given query types alone 
represent over half of all mean type weight (55.12).  The only other given query type with 
a mean type weight greater than 10 was Adverse Effects (16.69). 
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 Mechanism of Action was the given query type with the lowest mean type weight.  
This given query type had a mean type weight of less than 1 (.19).  Administration and 
Fertility, Pregnancy, or Lactation also had mean type weights of less than 1 (.54 and .58, 
respectively). 
 By way of exploratory investigation, this study will briefly discuss the differences 
between drugs in the opioid pharmacological category and drugs that are not.  In 
particular, the difference between opioids and non-opioids in terms of mean type weight 
for the Cost or Procurement drug information type will be investigated.  Below, Table 3 
shows results according to these categories. 
 Cost or Procurement 
(sum type weight) 
Not Cost or Procurement 
(sum type weight) 
Opioids 36.68 4963.32 
Non-opioids 85.79 4914.21 
Total 122.48 9877.52 
 Table 3: Sum type weights for the Cost or Procurement type and Not Cost or 
Procurement types (i.e., all other drug information types) according to drugs in the 
opioid category and those in other categories. 
 
This data lends itself to a Pearson‘s chi-squared test of the null hypothesis that drugs in 
the opioid class should be considered to belong to the same population as those that do 
not with respect to Cost or Procurement.  The resulting test statistic is 20.1 and the 
probability that this null hypothesis is true (p < .0001) supports rejecting the null 
hypothesis. 
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DISCUSSION 
 The above results contribute to three bodies of literature, namely, those 
concerning prescription drug information seeking behavior, the usefulness of prescription 
drug information, and infodemiology.  Results will be discussed in light of these bodies 
of literature.  This section will conclude with a discussion of limitations and by 
highlighting some of the work that could be done to build on the present study.  
 
Findings Concerning Prescription Drug Information Seeking Behavior 
 Hitherto, no drug information seeking behavior studies have described the types 
of drug information that people in the United States (US) search for.  The PEW study 
(Fox, 2009) and the Baker, Wagner, Singer, and Bundorf study (2003) both restricted 
their surveys to the extent to which people in the US use the Internet for drug-related 
information needs.  Neither asks the further question of what types of information are of 
interest.  The Ho, Ko, and Tan study (2009) does pose this further question, but in a 
population of mostly Chinese nationals visiting the outpatient pharmacy of the National 
University Hospital in Singapore.   
In addition, this paper has an important advantage over these studies, which all 
relied on surveys.  As Eysenbach and Kohler (2003) point out: ―direct analysis of 
searches elicits a much more accurate picture of what people are doing and looking for on 
the web than for example survey data such as the Pew Internet Survey, which currently 
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dominate the literature‖ (p. 229).  They reason:  
Not only is it difficult for people to recall in a survey which kind of information 
they retrieve on the web most frequently, the accuracy of survey data also suffers 
from a social desirability bias – rarely people will for example admit to be seeking 
pornographic material, although these kind of searches are apparently the most 
prevalent.  (229)  
 
These findings support this reasoning.  For example, the 45
th
 top search for the given 
query ―vicodin‖ was ―snort vicodin.‖  This may be less likely to have been self-reported 
than information needs that do not involve drug abuse. 
 On the other hand, surveys have merits that the present paper‘s method lacks.  For 
many top search queries, it is possible to make a valid inference from the query to a 
specific information need.  For instance, the top search query ―vicodin overdose‖ 
represents an information need having to do with vicodin overdoses.  In other cases, such 
inferences are not possible.  It is impossible to determine a specific information need 
from the top search query ―hydrocodone,‖ which is the main active ingredient of vicodin.  
For this reason, this author suggests a weakening of Eysenbach and Kohler‘s remarks 
regarding surveys.  In assessing prescription drug information seeking behavior, surveys 
are complementary to methods that directly measure online search behavior. 
 The results show that a high percentage of top search queries fell under the Drug 
Comparison (mean type weight = 23.13) and Drug-Drug or Drug-Herb Interaction 
(mean type weight = 2.65) query types.  These categories involving other drugs together 
account for over 25% of all mean type weight.  This suggests that information seeking 
behavior is not focused on single prescription drugs in isolation.  Rather, people in the 
US search for information about multiple drugs in succession.  Consumers may find 
information that places prescription drugs in the context of other prescription drugs to be 
 29 
helpful.  In particular, prescription drug information Web sites which allow simultaneous 
searches of multiple drugs and which return juxtaposed results along with any drug-drug 
interactions may be desirable to consumers.  
 
Findings Concerning the Usefulness of Prescription Drug Information 
 This paper also has findings that bear on the criteria used to assess the usefulness 
of online prescription drug information.  The drug information types that people seek – 
and therefore to some extent find useful – may be different from those corresponding to 
Consumer Medication Information.  Prima facie, it makes sense for consumers to have 
different information needs when turning to the Internet for prescription drug information 
vis-à-vis when reviewing the printed leaflets distributed by pharmacies with 
prescriptions.  Consumers searching the Web for prescription drug information do not 
necessarily have a prescription; they may be querying in order to determine whether they 
would receive therapeutic benefit from prescription drugs.  People in this position could 
be expected to have little interest in information having to do with administration and 
more interest in general questions, drug substitutes or comparisons, and adverse events.  
The mean type weights of the top search queries bear this out to some degree.  The mean 
type weight for Administration was 0.54, while those of General or Synonym, Drug 
Substitute or Comparison, and Adverse Events were 31.99, 23.13, and 16.69, 
respectively.  Of course, many people conducting Google searches for top 50 drugs will 
have been prescribed them, so it is not surprising that Dosing queries had a mean type 
weight of 8.77. 
 This author recommends that future studies not exclusively rely on FDA 
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guidelines concerning CMI for criteria to evaluate the usefulness of prescription drug 
information online.  Thompson and Graydon (2009) took this approach and used the 
following categories shown in Table 4 below. 
Criterion Description 
1 Drug names, indications for use, and how to monitor for improvement 
2 Contraindications and what to do if they apply 
3 Specific directions on how to use and store the medication and 
overdose information 
4 Specific precautions and warnings about the medication 
5 Symptoms of serious or frequent possible adverse reactions and what 
to do 
6 Certain general information including encouraging patients to 
communicate with health care professionals and disclaimer statements 
7 Information that is scientifically accurate, unbiased in tone and content, 
and up to date 
8 Information in an understandable and legible format that is readily 
comprehensible to consumers 
Table 4: Thompson and Graydon’s usefulness criteria for evaluating prescription drug 
information Web sites (2009, p. 42). 
 
These usefulness criteria fail to include a criterion that corresponds to the Drug Substitute 
or Comparison type, which had the second-highest mean type weight at 23.13. 
 Given that the General or Synonym type could have captured some information 
needs related to drugs‘ mechanism of action, it is impossible to infer from the fact that 
Mechanism of Action had the lowest mean type weight (0.19) to the conclusion that 
consumers do not have information needs along these lines.  It may be that consumers 
have difficulty formulating queries for this information type.  Or, it may be that 
consumers are more interested in what medications do than how they work.  
Qualitatively, this is supported by the present study, which uncovered many top search 
queries – some with high query weights – that asked about the effects of a particular drug. 
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Findings Concerning Infodemiology 
 Inasmuch as the literature of infodemiology overlaps with those of prescription 
drug information seeking behavior and drug information usefulness, the above findings 
are applicable to this literature.  By giving an overview of the types of prescription drug 
information searched for in the US, this study also provides groundwork for later 
infodemiology studies.  The following exploratory result is suggestive of the kind of 
studies that may follow this one.  The top 50 drugs can be organized according to 
pharmacologic class.  Opioids are one class that seemed to exhibit different mean type 
weights.  In particular, it seemed that more queries fell under the Cost or Procurement 
category for drugs in the opioid category.  Indeed, Pearson‘s chi-squared test supports 
rejecting the null hypothesis that drugs in the opioid category should be considered to 
belong to the same population as those that do not with respect to Cost or Procurement (p 
< .0001).  This finding could be useful as a marker of prescription drug abuse.  
Leveraging Insights for Search‘s geographic analysis feature, this information could be 
used as a means of assessing the extent of prescription drug abuse at the state or local 
level. 
 
Limitations and Suggestions for Future Work 
The coder, PC, described occasional uncertainty in deciding between the Drug-
Drug or Drug-Herb given query type and the Drug Substitute or Comparison type.  
Future studies should strive for two coders, which would allow inter-coder reliability 
assessment.  Primary care physicians or pharmacists represent ideal candidates for skilled 
coders.  
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Also, given queries comprised the top 50 prescribed drugs, and these are not 
likely to be representative of all drugs.  For instance, drugs indicated for rare conditions, 
―orphan drugs,‖ may be associated with different information needs and this may result in 
different mean type weights.  Future studies might explore orphan drugs.  Or, studies 
might rely on random sampling from a sampling frame including all FDA approved 
drugs. 
This paper provides evidence in support of distinguishing between usefulness 
criteria of CMI (i.e., the printed leaflets distributed at pharmacies) and those pertaining to 
online prescription drug information.  Future studies should not simply adopt FDA 
guidelines for the usefulness of CMI in order to evaluate the usefulness of prescription 
drug information on the Internet.  This is because guidelines for CMI do not emphasize 
the importance of placing information for a particular drug in the context of other drug 
information. 
By way of exploratory investigation, this study has also shown that drugs in the 
opioid category are characterized by different Cost or Procurement search behavior, 
which could be a useful marker of drug abuse.  Future infodemiology studies can use the 
drug information taxonomy as well as the mean type weights presented in this study to 
investigate other relationships that have the potential to improve public health outcomes. 
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CONCLUSIONS 
 This study has provided descriptive statistics on the type of information that 
people in the United States search for with respect to the most highly prescribed drugs.  
Using data from Google‘s Insights for Search, it has shown that searches for prescription 
drug information most often fall under the types General or Synonym, Drug Substitute or 
Comparison, and Adverse Effects.  Very few search queries fall under the types 
Mechanism of Action, Administration, and Fertility, Pregnancy, or Lactation. 
 This study has also shown that methodologies that exploit actual search behavior 
of large populations are important complements to large-scale surveys.  In particular, this 
study was able to move beyond the large-sample surveys conducted for the PEW Internet 
& American Life Project (Fox, 2009) and Baker, Wagner, Singer, and Bundorf (2003).  
Unlike these studies, the findings of this paper are not attended by the bias that may result 
from self-reported survey responses. 
 This study also provides evidence for the fact that the US population searches for 
prescription drug information, not in isolation, but in the context of other drugs. This 
population may find useful Web sites that juxtapose information about prescription drugs 
alongside that of other drugs.  Usefulness criteria specific to printed CMI should not be 
applied to online drug information Web sites without the addition of criteria that address 
the presence of contextual information about other drugs. 
 Finally, chi-squared tests showed that opioids differ from drugs not in the opioid 
 34 
category in terms of Cost or Procurement search behavior.  Future studies may establish 
this as a marker of drug abuse or may explore other categorical differences. 
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APPENDIX 
Rank (Number of 
Dispensations, 
2009) 
Given Query 
1 vicodin 
2 lipitor 
3 synthroid 
4 lisinopril 
5 amoxicillin 
6 nexium 
7 plavix 
8 toprol 
9 singulair 
10 lexapro 
11 proair 
12 simvastatin+zocor 
13 amlodipine+norvasc 
14 azithromycin 
15 metformin 
16 metoprolol 
17 hydrochlorothiazide 
18 crestor 
19 furosemide 
20 warfarin 
21 advair 
22 ibuprofen 
23 zoloft 
24 diovan 
Rank Given Query 
25 ambien 
26 percocet 
27 cymbalta 
28 seroquel 
29 effexor 
30 flomax 
31 xanax 
32 trazodone 
33 actos 
34 fosamax 
35 bactrim 
36 prevacid 
37 klonopin 
38 tramadol 
39 levaquin 
40 prozac 
41 prednisone 
42 prilosec 
43 atenolol 
44 lantus 
45 augmentin 
46 tricor 
47 celebrex 
48 aricept 
49 vytorin 
50 keflex 
Appendix: Given queries for the top 50 dispensed prescription drugs of 2009.  
 
